Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #51 to #300.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Air-kerma, entrance surface‏‎ (5 revisions)
  2. Fractionation sensitivity‏‎ (4 revisions)
  3. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  4. Optimisation‏‎ (4 revisions)
  5. High linear energy transfer radiation‏‎ (4 revisions)
  6. Sievert‏‎ (4 revisions)
  7. Computed tomography dose index‏‎ (4 revisions)
  8. Non-maleficence‏‎ (4 revisions)
  9. Direct bioassay‏‎ (4 revisions - redirect page)
  10. S coefficient (radiation weighted)‏‎ (4 revisions)
  11. Bioassay‏‎ (4 revisions)
  12. Calculating Radon Doses‏‎ (4 revisions)
  13. Alpha decay‏‎ (4 revisions)
  14. Effective charge number‏‎ (4 revisions)
  15. Mass median diameter‏‎ (4 revisions)
  16. Math‏‎ (4 revisions)
  17. Programmed cell death‏‎ (4 revisions)
  18. Effective half-life‏‎ (4 revisions)
  19. Averted dose‏‎ (4 revisions)
  20. Protective action‏‎ (4 revisions)
  21. Reference Animal and Plant‏‎ (4 revisions)
  22. Forbiddenness‏‎ (4 revisions)
  23. Aerodynamic diameter‏‎ (4 revisions)
  24. ICRP‏‎ (4 revisions)
  25. Kp index‏‎ (4 revisions)
  26. Diagnostic reference level‏‎ (4 revisions)
  27. Source-related assessment‏‎ (4 revisions)
  28. Reference bioassay function‏‎ (4 revisions)
  29. Air-kerma, product‏‎ (4 revisions)
  30. Risk‏‎ (4 revisions)
  31. Senescence‏‎ (4 revisions)
  32. Coster-Kronig transition‏‎ (3 revisions)
  33. Uptake‏‎ (3 revisions)
  34. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  35. Utilitarian ethics‏‎ (3 revisions)
  36. Operational quantity‏‎ (3 revisions)
  37. Emergency preparedness‏‎ (3 revisions)
  38. Gray‏‎ (3 revisions)
  39. Value judgement‏‎ (3 revisions)
  40. Emergency procedures‏‎ (3 revisions)
  41. Absolute risk‏‎ (3 revisions)
  42. Auger transition‏‎ (3 revisions)
  43. Bystander effect‏‎ (3 revisions)
  44. Complex tissues‏‎ (3 revisions)
  45. Valvular heart disease‏‎ (3 revisions)
  46. Derived air concentration‏‎ (3 revisions)
  47. Dignity‏‎ (3 revisions)
  48. Personal dose equivalent‏‎ (3 revisions)
  49. Principle of justification‏‎ (3 revisions)
  50. Employer‏‎ (3 revisions)
  51. Radiofrequency ablation‏‎ (3 revisions)
  52. Activity median thermodynamic diameter‏‎ (3 revisions)
  53. Lifetime risk estimates‏‎ (3 revisions)
  54. Virtue ethics‏‎ (3 revisions)
  55. Growth fraction‏‎ (3 revisions)
  56. Iso-effect plots‏‎ (3 revisions)
  57. Voxel phantom‏‎ (3 revisions)
  58. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  59. Excretion rate (instantaneous)‏‎ (3 revisions)
  60. Extrathoracic airways‏‎ (3 revisions)
  61. Galactic cosmic radiation‏‎ (3 revisions)
  62. Growth hormone (somatotropin)‏‎ (3 revisions)
  63. ICRP Publication 103‏‎ (3 revisions)
  64. Isomers‏‎ (3 revisions)
  65. DNA damage signalling‏‎ (3 revisions)
  66. Organ dose equivalent‏‎ (3 revisions)
  67. Fairness‏‎ (3 revisions)
  68. Absorption‏‎ (3 revisions)
  69. Gamma ray‏‎ (3 revisions)
  70. Dose equivalent‏‎ (3 revisions)
  71. Field-size effect (Volume effect)‏‎ (3 revisions)
  72. Gastrointestinal syndrome‏‎ (3 revisions)
  73. Biomedical research volunteer‏‎ (3 revisions)
  74. Cardiomyopathy‏‎ (3 revisions)
  75. Dose limit‏‎ (3 revisions)
  76. Recovery‏‎ (3 revisions)
  77. Flexible tissues‏‎ (3 revisions)
  78. Guide to the System of Radiological Protection‏‎ (3 revisions)
  79. Autonomy‏‎ (3 revisions)
  80. Spread-out Bragg peak‏‎ (3 revisions)
  81. Constancy test‏‎ (3 revisions)
  82. Wisdom‏‎ (3 revisions)
  83. Dose‏‎ (3 revisions)
  84. Dose limits‏‎ (3 revisions)
  85. Fluence‏‎ (3 revisions)
  86. Target region‏‎ (3 revisions)
  87. DS02‏‎ (3 revisions)
  88. Fluoroscopically guided interventions‏‎ (3 revisions)
  89. Annual dose‏‎ (3 revisions)
  90. Contamination‏‎ (3 revisions)
  91. Dose of record (E)‏‎ (3 revisions)
  92. Accountability‏‎ (3 revisions)
  93. Half-life, physical‏‎ (3 revisions)
  94. Cell death‏‎ (3 revisions)
  95. Potential exposure‏‎ (3 revisions)
  96. Exponential survival curve‏‎ (3 revisions)
  97. Annual limit on intake‏‎ (3 revisions)
  98. Low Earth orbit‏‎ (3 revisions)
  99. X ray‏‎ (3 revisions)
  100. Dose per content function‏‎ (3 revisions)
  101. Equity‏‎ (3 revisions)
  102. Graded approach‏‎ (3 revisions)
  103. Rigidity threshold‏‎ (3 revisions)
  104. Unsealed source‏‎ (3 revisions)
  105. Xerostomia‏‎ (3 revisions)
  106. Fractionation‏‎ (3 revisions)
  107. Test‏‎ (3 revisions)
  108. Public exposure‏‎ (3 revisions)
  109. Active (red) bone marrow‏‎ (3 revisions)
  110. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  111. Interphase death‏‎ (3 revisions)
  112. Latent time/period or latency interval‏‎ (2 revisions)
  113. Class SR-2 gases‏‎ (2 revisions)
  114. Low level waste‏‎ (2 revisions)
  115. Committed equivalent dose‏‎ (2 revisions)
  116. Dichotomous‏‎ (2 revisions)
  117. Dose rate effectiveness factor‏‎ (2 revisions)
  118. Qualified expert‏‎ (2 revisions)
  119. Emergency plan‏‎ (2 revisions)
  120. Radioactive substance‏‎ (2 revisions)
  121. Ethics‏‎ (2 revisions)
  122. ALARA‏‎ (2 revisions)
  123. Reference biokinetic model‏‎ (2 revisions)
  124. Relocation‏‎ (2 revisions)
  125. Risk coefficient‏‎ (2 revisions)
  126. Hierarchical tissues‏‎ (2 revisions)
  127. Area monitoring‏‎ (2 revisions)
  128. Individual monitoring‏‎ (2 revisions)
  129. Benthic‏‎ (2 revisions)
  130. Source term‏‎ (2 revisions)
  131. Bronchial region‏‎ (2 revisions)
  132. Substantial radiation dose level‏‎ (2 revisions)
  133. Clearance‏‎ (2 revisions)
  134. Transfer rate‏‎ (2 revisions)
  135. Multi-detector computed tomography‏‎ (2 revisions)
  136. Deontological Ethics‏‎ (2 revisions)
  137. Differentiation‏‎ (2 revisions)
  138. Percutaneous coronary intervention‏‎ (2 revisions)
  139. Prevailing circumstances‏‎ (2 revisions)
  140. Radon Recommendations for Authorities‏‎ (2 revisions)
  141. Reference individual‏‎ (2 revisions)
  142. Activity‏‎ (2 revisions)
  143. Remedial action‏‎ (2 revisions)
  144. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  145. High level waste‏‎ (2 revisions)
  146. Intervention Level‏‎ (2 revisions)
  147. Clearance level‏‎ (2 revisions)
  148. Lymphatic system‏‎ (2 revisions)
  149. Transforming growth factor‏‎ (2 revisions)
  150. Pericarditis‏‎ (2 revisions)
  151. Dose constraint‏‎ (2 revisions)
  152. Principle of application of dose limits‏‎ (2 revisions)
  153. Early normal tissue responses‏‎ (2 revisions)
  154. Radioactivity‏‎ (2 revisions)
  155. Radon Recommendations for Workplaces‏‎ (2 revisions)
  156. Reference level‏‎ (2 revisions)
  157. Remediation‏‎ (2 revisions)
  158. Risk of Exposure to Radon‏‎ (2 revisions)
  159. Beta-minus decay‏‎ (2 revisions)
  160. South Atlantic anomaly‏‎ (2 revisions)
  161. Interventional procedure‏‎ (2 revisions)
  162. Lifetime risk‏‎ (2 revisions)
  163. Macrophage colony stimulating factor‏‎ (2 revisions)
  164. Multiplicative risk projection model‏‎ (2 revisions)
  165. Cumulative dose‏‎ (2 revisions)
  166. Dose conversion coefficient‏‎ (2 revisions)
  167. Edema‏‎ (2 revisions)
  168. Excess relative risk‏‎ (2 revisions)
  169. Exposure situation‏‎ (2 revisions)
  170. Repopulation‏‎ (2 revisions)
  171. Growth factor‏‎ (2 revisions)
  172. Alimentary tract transfer factor‏‎ (2 revisions)
  173. Routine monitoring‏‎ (2 revisions)
  174. ICRPædia Guide to Radon‏‎ (2 revisions)
  175. Beta-plus decay‏‎ (2 revisions)
  176. Special (non-routine) monitoring‏‎ (2 revisions)
  177. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  178. Clonogenic cells‏‎ (2 revisions)
  179. Threshold dose for tissue reactions‏‎ (2 revisions)
  180. Magnetosphere‏‎ (2 revisions)
  181. Curie‏‎ (2 revisions)
  182. Effect Dose 50‏‎ (2 revisions)
  183. Endogeneous excretion‏‎ (2 revisions)
  184. Radiographer‏‎ (2 revisions)
  185. Exposure to Radon at Home‏‎ (2 revisions)
  186. GATA binding protein 2‏‎ (2 revisions)
  187. Representative organism (non-human biota)‏‎ (2 revisions)
  188. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  189. Hormones‏‎ (2 revisions)
  190. Authorization‏‎ (2 revisions)
  191. Limitation of dose‏‎ (2 revisions)
  192. Clonogenic survival‏‎ (2 revisions)
  193. Transmission detection system‏‎ (2 revisions)
  194. Multistage tumorigenesis‏‎ (2 revisions)
  195. Cytokines‏‎ (2 revisions)
  196. Non-sphericity parameter‏‎ (2 revisions)
  197. Pharynx‏‎ (2 revisions)
  198. Acute radiation syndrome‏‎ (2 revisions)
  199. Representative person‏‎ (2 revisions)
  200. Safety‏‎ (2 revisions)
  201. Hounsfield unit‏‎ (2 revisions)
  202. Authorized limit‏‎ (2 revisions)
  203. Specific effective energy‏‎ (2 revisions)
  204. Cardiac arrhythmias‏‎ (2 revisions)
  205. Lineal energy‏‎ (2 revisions)
  206. Thyroid blocking‏‎ (2 revisions)
  207. Transparency‏‎ (2 revisions)
  208. Waste disposal‏‎ (2 revisions)
  209. Non-targeted effects‏‎ (2 revisions)
  210. Disposal‏‎ (2 revisions)
  211. Dose criteria‏‎ (2 revisions)
  212. Procedural values‏‎ (2 revisions)
  213. Environmental exposure‏‎ (2 revisions)
  214. Exempt waste‏‎ (2 revisions)
  215. Adaptive response‏‎ (2 revisions)
  216. Reproductive integrity‏‎ (2 revisions)
  217. Alveolar-interstitial region‏‎ (2 revisions)
  218. Safety case‏‎ (2 revisions)
  219. Autoimmune disease‏‎ (2 revisions)
  220. Slow repair‏‎ (2 revisions)
  221. Isotropic geometry‏‎ (2 revisions)
  222. ICRP Publication 118‏‎ (2 revisions)
  223. Cardiac valve diseases‏‎ (2 revisions)
  224. Linear-non-threshold model‏‎ (2 revisions)
  225. Co-expertise‏‎ (2 revisions)
  226. Connective tissue‏‎ (2 revisions)
  227. Trapped particles‏‎ (2 revisions)
  228. DRL process‏‎ (2 revisions)
  229. Orphan source‏‎ (2 revisions)
  230. Planned exposure situation‏‎ (2 revisions)
  231. Progenitor cell‏‎ (2 revisions)
  232. Radiation belt‏‎ (2 revisions - redirect page)
  233. Environmental radiation protection‏‎ (2 revisions)
  234. Exemption level‏‎ (2 revisions)
  235. Reasonableness‏‎ (2 revisions)
  236. Residual dose‏‎ (2 revisions)
  237. Safety culture‏‎ (2 revisions)
  238. Solar cosmic radiation‏‎ (2 revisions)
  239. Inhalability‏‎ (2 revisions)
  240. Spontaneous fission‏‎ (2 revisions)
  241. Itinerant (radiation) worker‏‎ (2 revisions)
  242. Systemic model‏‎ (2 revisions)
  243. Linear-quadratic dose response model‏‎ (2 revisions)
  244. Time factor‏‎ (2 revisions)
  245. Consequential late effects‏‎ (2 revisions)
  246. Myocardial perfusion‏‎ (2 revisions)
  247. What is Radon?‏‎ (2 revisions)
  248. Platelet-derived growth factor‏‎ (2 revisions)
  249. Effective dose equivalent‏‎ (2 revisions)
  250. Radiation modifier‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)